Evotec's aseptic manufacturing facilities are MHRA approved and operate to cGMP standards. Our clean room suites have integrated lyophilisers and there are dedicated facilities for the manufacture of non-cytotoxic and cytotoxic drug product. The clean room suites operate to Class A, B and C and the manufacturing capacity can produce sufficient materials for phase I and II clinical batches.
Small molecules and biologicals can also be aseptically manufactured by our experienced teams and our flexible filling processes allow us to fill into vials, syringes or ampoules.
Manufactured batches can be tested for sterility / stability and other parameters in accordance to current guidelines and customer requirements. All work is overseen by a regulatory team to ensure compliance and give confidence that clinical trials supplies will be aseptically manufactured to the highest standards.